Laurence Hurley, PhD, Howard Schaeffer Endowed Chair in Pharmaceutical Sciences (College of Pharmacy) and Associate Director of BIO5. Dr. Hurley's was recognized for the development of anti pancreatic cancer drugs and their commercialization using iRNA biotechnology. The drugs are being developed by Cylene Pharmaceuticals, of which he was the Scientific Founder.
March 2007
All Comments